SCHEDULE: T. Rowe Price Discloses 9.7% Stake in Perrigo Co PLC

Sentiment:

Beneficial Ownership Filing


T. Rowe Price Associates, Inc. has reported a beneficial ownership of 9.7% in Perrigo Co PLC, holding over 13.3 million shares as of March 31, 2026.

Summary

  • T. Rowe Price Associates, Inc. has filed a Schedule 13G, indicating a significant beneficial ownership in Perrigo Co PLC.
  • The filing, dated March 31, 2026, shows T. Rowe Price Associates, Inc. beneficially owns 13,376,708 shares of Perrigo Co PLC's common stock.
  • This represents 9.7% of the class of securities.
  • The reporting entity, T. Rowe Price Associates, Inc., is an investment adviser organized in Maryland.
  • The filing clarifies that T. Rowe Price Associates, Inc. does not serve as custodian for client assets, and ultimate power for dividends and sale proceeds rests with individual and institutional clients, unless specific T. Rowe Price Funds are involved.
  • Specifically, the T. ROWE PRICE MID-CAP VALUE FUND holds 7,498,410 shares, representing 5.4% of the class.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms a significant investment by a reputable asset manager, but it does not provide new operational or financial performance data for Perrigo Co PLC itself.

Positives

  • T. Rowe Price Associates, Inc. has a substantial beneficial ownership stake of 9.7% in Perrigo Co PLC, indicating confidence from a major investment manager.
  • The T. ROWE PRICE MID-CAP VALUE FUND specifically holds a significant portion (5.4%) of the class, suggesting a focused investment within this fund.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from Perrigo Co PLC.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major investment manager like T. Rowe Price Associates, Inc. often signifies a significant investment position, potentially influencing market perception and investor interest in the pharmaceutical and consumer self-care sectors where Perrigo operates.

Stakeholder Impact

  • Shareholders: The filing confirms a significant stake by T. Rowe Price Associates, Inc., which may be viewed positively by existing shareholders as an endorsement of the company's value. It also clarifies the nature of beneficial ownership for clients.
  • Investment Community: This disclosure provides transparency regarding a major institutional investor's position, aiding in market analysis and valuation.

Key Dates

DateDescription
03/31/2026Date of Event Which Requires Filing of this Statement
05/07/2026Signature Date of T. Rowe Price Associates, Inc.

Keywords

Perrigo Co PLC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, Securities Filing, Shareholder

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.